Corvus Pharmaceuticals, Inc. — Director's Dealing 2022

Jun 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2022-06-02

Reporting Person: MILLER RICHARD A MD (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-02	Common Stock	P	4830	$0.98	Acquired	1338345	Indirect
2022-06-02	Common Stock	P	170	$0.97	Acquired	1338515	Indirect
2022-06-06	Common Stock	P	890	$1.01	Acquired	1339405	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	35714	Direct

Footnotes

F1: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.